NCT06332131 Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature Status ENROLLING_BY_INVITATION Phase N/A
NCT06331169 Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer Status RECRUITING Phase PHASE1
NCT06327607 Psychosexuological Interventions to Support Sexual Function in Breast Cancer Patients Status RECRUITING Phase N/A
NCT06327490 A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer Status RECRUITING Phase PHASE2
NCT06324721 Who and Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable Swelling Status RECRUITING Phase NA
NCT06322888 Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D) Status RECRUITING Phase NA
NCT06321653 Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes Status RECRUITING Phase N/A
NCT06321640 Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies. Status RECRUITING Phase N/A
NCT06319209 Timing of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 Infection Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06317948 Improving the Quality of Radiotherapy by Multi-Institution Knowledge-Based Planning Optimization Models (Acronym: MIKAPOCo, Multi-Institutional Knowledge-based Approach in Plan Optimization for the Community) Status ENROLLING_BY_INVITATION Phase N/A
NCT06315868 Breast Cancer Subtype Characterization Through Patient's Derived Organoids. Status RECRUITING Phase N/A
NCT06313983 A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer Status RECRUITING Phase PHASE3
NCT06313476 AMH Predicts Postchemotherapy Menopause in Premenopausal Breast Cancer Patients Status NOT_YET_RECRUITING Phase N/A
NCT06311383 A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment Status COMPLETED Phase N/A
NCT06309290 Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy Status RECRUITING Phase NA
NCT06308029 Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer Treatment Status RECRUITING Phase NA